Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. April 2015 08:30 ET | Quelle: Focus Ventures Ltd.

Focus Initiates Phase 2 Drilling at Its Bayovar 12 Phosphate Project, Peru

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 14, 2015) - Focus Ventures Ltd. (TSX VENTURE:FCV) ("Focus" or the "Company") is pleased to announce that its Phase 2 drill program has...
14. April 2015 08:00 ET | Quelle: Argos Therapeutics, Inc.

Argos Therapeutics Licenses Arcelis(R) Technology Platform to Lummy HK for Development of Personalized Immunotherapies to Treat Cancer in China

DURHAM, N.C., April 14, 2015 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS) ("Argos"), a biopharmaceutical company focused on the development and commercialization of fully personalized...
14. April 2015 08:00 ET | Quelle: BioMarin Pharmaceutical Inc.

BioMarin to Host First Quarter 2015 Financial Results Conference Call and Webcast on Thursday, April 30 at 4:30pm ET

SAN RAFAEL, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
14. April 2015 07:21 ET | Quelle: Galena Biopharma, Inc.

Galena Biopharma Completes Over-Enrollment of NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial

PORTLAND, Ore., April 14, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that...
14. April 2015 07:00 ET | Quelle: Serinus Energy Inc.

Serinus Energy-Q1 2015 Operations Update

CALGARY, ALBERTA--(Marketwired - April 14, 2015) - Serinus Energy Inc. ("Serinus", "SEN" or the "Company") (TSX:SEN)(WARSAW:SEN) is pleased to provide the following update for its...
13. April 2015 16:05 ET | Quelle: GW Pharmaceuticals plc

GW Pharmaceuticals Notes New Epidiolex(R) Data Released by the American Academy of Neurology

LONDON, April 13, 2015 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and...
13. April 2015 15:07 ET | Quelle: Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market

NORWOOD, MA--(Marketwired - Apr 13, 2015) - Corbus Pharmaceuticals Holdings, Inc. (OTCQB: CRBP) (the Company), an emerging drug development company focused on the development and commercialization...
13. April 2015 14:51 ET | Quelle: Gradalis, Inc.

Gradalis, Inc. Announces Presentation of Phase 2 Data of Ovarian Cancer Patients Treated With Vigil(TM)

DALLAS, April 13, 2015 (GLOBE NEWSWIRE) -- Gradalis Inc., a late-stage biopharmaceutical company, today announced that Phase 2 data for its proprietary personalized immunotherapy, Vigil™ (previously...
13. April 2015 08:30 ET | Quelle: Karyopharm Therapeutics

Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330)

NEWTON, Mass., April 13, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the issuance of U.S. Patent No. 8,999,996...
13. April 2015 08:30 ET | Quelle: Aravive, Inc.

Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency

MENLO PARK, Calif., April 13, 2015 (GLOBE NEWSWIRE) -- Versartis, Inc. (Nasdaq:VSAR), an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human...

Vorherige Seite

Nächste Seite